Candel Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Needham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Candel Therapeutics, Inc. has filed 400 SEC EDGAR filings since 16 Feb 2021

SEC filing history

Showing 1-1 of 1 matching filings.

Per page
25
Current page
1
SC 13D File 005-93359

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .